Cu2+ ions modulate the interaction between α-synuclein and lipid membranes.
Hongzhi Wang1, Cecilia Mörman2, Rebecca Sternke-Hoffmann1
1Department of Biology and Chemistry, Paul Scherrer Institute, 5232 Villigen, Switzerland.
Copper ions and lipid membranes influence alpha-synuclein aggregation, a key factor in Parkinson's disease. This study reveals how these factors interact, offering insights into disease mechanisms.
Area of Science:
- Biochemistry
- Neuroscience
- Structural Biology
Background:
- Alpha-synuclein protein aggregates form Lewy bodies, a hallmark of Parkinson's disease.
- Lipid membranes and copper (Cu2+) ions are known to bind alpha-synuclein, affecting its aggregation and toxicity.
- The combined effect of copper ions and lipid membranes on alpha-synuclein remains largely unexplored.
Purpose of the Study:
- To investigate the synergistic effects of Cu2+ ions and lipid membranes on alpha-synuclein.
- To elucidate how these factors modulate the structure and aggregation of alpha-synuclein.
- To understand the implications for the molecular pathogenesis of Parkinson's disease.
Main Methods:
- Small-angle X-ray scattering (SAXS) to analyze the influence on lipidic cubic phase (LCP) structure.
- Circular dichroism (CD) spectroscopy to study changes in alpha-synuclein secondary structure.
- Nuclear magnetic resonance (NMR) spectroscopy for atomic-level structural insights.
Main Results:
- Alpha-synuclein destabilizes the cubic-Pn3m phase of LCP, which is restored by Cu2+ ions.
- Cu2+ ions do not significantly alter the secondary structure of alpha-synuclein in the presence of lipid membranes.
- Lipid membranes facilitate the interaction between the C-terminus of alpha-synuclein and Cu2+ ions.
Conclusions:
- Cu2+ ions and lipid membranes exhibit a modulatory effect on alpha-synuclein structure and dynamics.
- These interactions, particularly at the C-terminus, may be crucial in the molecular mechanisms of Parkinson's disease.
- Understanding these synergistic effects provides new avenues for exploring Parkinson's disease pathogenesis.
More Related Videos
15:04Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
07:56Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time
Published on: May 30, 2021
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Regulation of Nuclear Protein Sorting
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
